January 12, 2016 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Alexion Pharmaceuticals, Inc., a stock transaction, valued at $50,001 - $100,000. The trade took place on January 12, 2016 and was disclosed on February 8, 2016 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.